Advertisement

China’s coronavirus vaccines: is Southeast Asia ready to trust them?

  • A soft power victory beckons if Beijing can help nurse its neighbours back to health – but the stakes are high, trust is low and failure would be disastrous
  • Key to its drive is Indonesia, which has secured doses of three potential vaccines from China. If they work, success could be contagious

Reading Time:9 minutes
Why you can trust SCMP
A worker checks syringes on the production line at Sinovac Biotech in Beijing, China. Photo: TNS
Fadli Barjadi Kusuma was petrified when he arrived in a grand, leafy building of a university medical school in his hometown of Bandung, Indonesia, in mid August.
Advertisement
The motorcycle-taxi driver was there to take part in the late-stage clinical trial of a Covid-19 vaccine made by Beijing-based Sinovac Biotech.

“I was very scared, because my life was at risk. But I had set my mind to be a volunteer, I knew the risks, so I was finally ready. God willing, I would be fine,” Fadli, 32, said.

Fadli, who learned about the trial from a relative, wanted to volunteer because his job requires physical contact with other people.

“I want to protect myself and help the government. I am really affected by this pandemic. I can’t set up my own business because I have no money, jobs are scarce so it’s hard just to afford to eat,” said the father of three, who earns about two million rupiah (US$140) a month.

Advertisement

Fadli has received two doses in the vaccine trial. Three months after his second dose, Fadli says he feels great and confident enough to drive the tree-lined streets of Bandung on his two-wheeler.

Advertisement